Entity Conversion

Recorded: 2018-09-05 Pages: 9

Assignor

AROG PHARMACEUTICALS, LLC

Executed: 2014-09-30

Assignee

AROG PHARMACEUTICALS, INC.

5420 LBJ FREEWAY, STE. 410, TWO LINCOLN CENTRE, DALLAS, TEXAS, 75240

Covered Property (1)

Method of Inhibiting Constitutively Active Phosphorylated FLT3 Kinase

Patent: 9,023,880 →

Application: 14/026,778 →

Publication: US 2014/0088143

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.